Fourth-quarter profits at Natick medical device company Boston Scientific Corp. fell 45 percent to $107 million, compared with $236 million in Q4 2010.
The company’s sales dropped 8 percent to $1.8 billion in the fourth quarter, driven by declines in its two largest sectors, interventional cardiology and cardiac rhythm management.
For the full year, sales fell 2 percent to $7.6 billion. The company made a profit of $441 million for the year after losing $1.1 billion in 2010.
